Logo image of STAI

SCANTECH AI SYSTEMS INC (STAI) Stock Fundamental Analysis

NASDAQ:STAI - Nasdaq - US80603V1044 - Common Stock - Currency: USD

0.469  -0.03 (-6.18%)

After market: 0.69 +0.22 (+47.12%)

Fundamental Rating

0

Overall STAI gets a fundamental rating of 0 out of 10. We evaluated STAI against 124 industry peers in the Electronic Equipment, Instruments & Components industry. STAI has a bad profitability rating. Also its financial health evaluation is rather negative. STAI is valued expensive and it does not seem to be growing.


Dividend Valuation Growth Profitability Health

Quickly go to:

0

1. Profitability

1.1 Basic Checks

STAI had negative earnings in the past year.
In the past year STAI has reported a negative cash flow from operations.
STAI Yearly Net Income VS EBIT VS OCF VS FCFSTAI Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2021 2022 2023 2024 0 -5M -10M -15M -20M

1.2 Ratios

STAI's Return On Assets of -32.26% is on the low side compared to the rest of the industry. STAI is outperformed by 79.03% of its industry peers.
Industry RankSector Rank
ROA -32.26%
ROE N/A
ROIC N/A
ROA(3y)-356.37%
ROA(5y)N/A
ROE(3y)N/A
ROE(5y)N/A
ROIC(3y)N/A
ROIC(5y)N/A
STAI Yearly ROA, ROE, ROICSTAI Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2021 2022 2023 2024 0 -200 -400 -600 -800 -1K

1.3 Margins

STAI's Gross Margin of 24.41% is in line compared to the rest of the industry. STAI outperforms 40.32% of its industry peers.
The Profit Margin and Operating Margin are not available for STAI so they could not be analyzed.
Industry RankSector Rank
OM N/A
PM (TTM) N/A
GM 24.41%
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3YN/A
GM growth 5YN/A
STAI Yearly Profit, Operating, Gross MarginsSTAI Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2021 2022 2023 2024 0 -1K -2K -3K -4K

More info and screens

0

2. Health

2.1 Basic Checks

STAI does not have a ROIC to compare to the WACC, probably because it is not profitable.
STAI has more shares outstanding than it did 1 year ago.
STAI has a worse debt/assets ratio than last year.
STAI Yearly Shares OutstandingSTAI Yearly Shares OutstandingYearly Shares Outstanding 2021 2022 2023 2024 5M 10M 15M
STAI Yearly Total Debt VS Total AssetsSTAI Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2021 2022 2023 2024 20M 40M 60M

2.2 Solvency

Industry RankSector Rank
Debt/Equity N/A
Debt/FCF N/A
Altman-Z N/A
ROIC/WACCN/A
WACC8.69%
STAI Yearly LT Debt VS Equity VS FCFSTAI Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2021 2022 2023 2024 0 50M -50M -100M -150M

2.3 Liquidity

STAI has a Current Ratio of 0.12. This is a bad value and indicates that STAI is not financially healthy enough and could expect problems in meeting its short term obligations.
With a Current ratio value of 0.12, STAI is not doing good in the industry: 99.19% of the companies in the same industry are doing better.
A Quick Ratio of 0.09 indicates that STAI may have some problems paying its short term obligations.
STAI's Quick ratio of 0.09 is on the low side compared to the rest of the industry. STAI is outperformed by 99.19% of its industry peers.
Industry RankSector Rank
Current Ratio 0.12
Quick Ratio 0.09
STAI Yearly Current Assets VS Current LiabilitesSTAI Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2021 2022 2023 2024 50M 100M 150M

More info and screens

0

3. Growth

3.1 Past

The earnings per share for STAI have decreased strongly by -128.19% in the last year.
EPS 1Y (TTM)-128.19%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%-643.66%
Revenue 1Y (TTM)N/A
Revenue growth 3YN/A
Revenue growth 5YN/A
Sales Q2Q%N/A

3.2 Future

No EPS estimates are available, so we could not analyze the future EPS growth and evolution.
No Revenue estimates are available, so we could not analyze the future revenue growth and evolution.
EPS Next YN/A
EPS Next 2YN/A
EPS Next 3YN/A
EPS Next 5YN/A
Revenue Next YearN/A
Revenue Next 2YN/A
Revenue Next 3YN/A
Revenue Next 5YN/A

3.3 Evolution

No EPS estimates are available, so we could not analyze the future EPS growth and evolution.
No Revenue estimates are available, so we could not analyze the future revenue growth and evolution.
STAI Yearly Revenue VS EstimatesSTAI Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2024 100K 200K 300K 400K 500K

More info and screens

0

4. Valuation

4.1 Price/Earnings Ratio

The Price/Earnings Ratio is negative for STAI. In the last year negative earnings were reported.
Industry RankSector Rank
PE N/A
Fwd PE N/A
STAI Price Earnings VS Forward Price EarningsSTAI Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 0 0 0 0 0 0 0 0 0 0 0

4.2 Price Multiples

Industry RankSector Rank
P/FCF N/A
EV/EBITDA N/A
STAI Per share dataSTAI EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 0 -0.2 -0.4 -0.6 -0.8 -1

4.3 Compensation for Growth

PEG (NY)N/A
PEG (5Y)N/A
EPS Next 2YN/A
EPS Next 3YN/A

More info and screens

0

5. Dividend

5.1 Amount

No dividends for STAI!.
Industry RankSector Rank
Dividend Yield N/A

More info and screens

SCANTECH AI SYSTEMS INC

NASDAQ:STAI (8/19/2025, 8:19:29 PM)

After market: 0.69 +0.22 (+47.12%)

0.469

-0.03 (-6.18%)

Chartmill FA Rating
GICS SectorInformation Technology
GICS IndustryGroupTechnology Hardware & Equipment
GICS IndustryElectronic Equipment, Instruments & Components
Earnings (Last)N/A N/A
Earnings (Next)N/A N/A
Inst Owners42.16%
Inst Owner Change165.33%
Ins Owners14.67%
Ins Owner Change80.43%
Market Cap22.63M
AnalystsN/A
Price TargetN/A
Short Float %3.21%
Short Ratio0.15
Dividend
Industry RankSector Rank
Dividend Yield N/A
Yearly DividendN/A
Dividend Growth(5Y)N/A
DPN/A
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)N/A
Avg EPS beat(2)N/A
Min EPS beat(2)N/A
Max EPS beat(2)N/A
EPS beat(4)N/A
Avg EPS beat(4)N/A
Min EPS beat(4)N/A
Max EPS beat(4)N/A
EPS beat(8)N/A
Avg EPS beat(8)N/A
EPS beat(12)N/A
Avg EPS beat(12)N/A
EPS beat(16)N/A
Avg EPS beat(16)N/A
Revenue beat(2)N/A
Avg Revenue beat(2)N/A
Min Revenue beat(2)N/A
Max Revenue beat(2)N/A
Revenue beat(4)N/A
Avg Revenue beat(4)N/A
Min Revenue beat(4)N/A
Max Revenue beat(4)N/A
Revenue beat(8)N/A
Avg Revenue beat(8)N/A
Revenue beat(12)N/A
Avg Revenue beat(12)N/A
Revenue beat(16)N/A
Avg Revenue beat(16)N/A
PT rev (1m)N/A
PT rev (3m)N/A
EPS NQ rev (1m)N/A
EPS NQ rev (3m)N/A
EPS NY rev (1m)N/A
EPS NY rev (3m)N/A
Revenue NQ rev (1m)N/A
Revenue NQ rev (3m)N/A
Revenue NY rev (1m)N/A
Revenue NY rev (3m)N/A
Valuation
Industry RankSector Rank
PE N/A
Fwd PE N/A
P/S 58.71
P/FCF N/A
P/OCF N/A
P/B N/A
P/tB N/A
EV/EBITDA N/A
EPS(TTM)-0.08
EYN/A
EPS(NY)N/A
Fwd EYN/A
FCF(TTM)-0.21
FCFYN/A
OCF(TTM)-0.21
OCFYN/A
SpS0.01
BVpS-1.16
TBVpS-1.16
PEG (NY)N/A
PEG (5Y)N/A
Profitability
Industry RankSector Rank
ROA -32.26%
ROE N/A
ROCE N/A
ROIC N/A
ROICexc N/A
ROICexgc N/A
OM N/A
PM (TTM) N/A
GM 24.41%
FCFM N/A
ROA(3y)-356.37%
ROA(5y)N/A
ROE(3y)N/A
ROE(5y)N/A
ROIC(3y)N/A
ROIC(5y)N/A
ROICexc(3y)N/A
ROICexc(5y)N/A
ROICexgc(3y)N/A
ROICexgc(5y)N/A
ROCE(3y)N/A
ROCE(5y)N/A
ROICexcg growth 3YN/A
ROICexcg growth 5YN/A
ROICexc growth 3YN/A
ROICexc growth 5YN/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3YN/A
GM growth 5YN/A
F-Score1
Asset Turnover0.07
Health
Industry RankSector Rank
Debt/Equity N/A
Debt/FCF N/A
Debt/EBITDA N/A
Cap/Depr N/A
Cap/Sales N/A
Interest Coverage N/A
Cash Conversion N/A
Profit Quality N/A
Current Ratio 0.12
Quick Ratio 0.09
Altman-Z N/A
F-Score1
WACC8.69%
ROIC/WACCN/A
Cap/Depr(3y)40.84%
Cap/Depr(5y)N/A
Cap/Sales(3y)N/A
Cap/Sales(5y)N/A
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)-128.19%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%-643.66%
EPS Next YN/A
EPS Next 2YN/A
EPS Next 3YN/A
EPS Next 5YN/A
Revenue 1Y (TTM)N/A
Revenue growth 3YN/A
Revenue growth 5YN/A
Sales Q2Q%N/A
Revenue Next YearN/A
Revenue Next 2YN/A
Revenue Next 3YN/A
Revenue Next 5YN/A
EBIT growth 1Y-2011.18%
EBIT growth 3YN/A
EBIT growth 5YN/A
EBIT Next YearN/A
EBIT Next 3YN/A
EBIT Next 5YN/A
FCF growth 1Y-2277.79%
FCF growth 3YN/A
FCF growth 5YN/A
OCF growth 1Y-2275.74%
OCF growth 3YN/A
OCF growth 5YN/A